GENHEALTH has filed a notice of an exempt offering of securities to raise $16,499,983.00 in New Funding.

According to filings with the U.S. Securities and Exchange Commission, GENHEALTH is raising up to $16,499,983.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About GENHEALTH
GENHEALTH provides generative AI for healthcare operations, focusing on revenue cycle management and administrative tasks such as intake, eligibility, prior authorization, billing, claims, denials, and appeals. Its AI agents automate work across websites, portals, electronic medical records, billing systems, faxed documents, and phone outreach while using context from provider actions, health-plan policies, and patient charts. The company serves health plans, providers, revenue cycle management teams, and durable medical equipment organizations through workflow automation, automated RCM, full-service RCM, and policy and coverage tools. GENHEALTH states that its full-service RCM offering achieves more than 95% first-pass claim acceptance and reduces days sales outstanding by 40%. Customer results highlighted on the site include a 34.2% increase in paid-to-date collections with a 6.6x ROI for Piedmont Medical Solutions and projected annual administrative savings of up to $1.2 million with a 6.9x ROI for GuideHealth. The company also announces that it has raised Series A funding.

To learn more, visit https://genhealth.ai/
LinkedIn: https://www.linkedin.com/company/genhealth-ai/

Contact:
Ritwik Sahu, Chief Executive Officer
https://www.linkedin.com/in/ricky-sahu/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.